Skip to main content
Solomon Hamburg, MD, Oncology, Los Angeles, CA

Solomon I. Hamburg MD

Oncology•Los Angeles, CA

Breast Cancer, Hematologic Oncology, Thoracic Cancer

Oncology/UCLA Health/Clinical Professor of Medicine

Join to view full profile

  • 10833 LeConte Ave60-054 CHSLos Angeles, CA 90095

  • Phone+1 310-825-5756

  • Fax+1 310-825-5756

Dr. Hamburg is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Hamburg's full profileAlready have an account?

Summary

  • Dr. Solomon Hamburg is an oncology specialist based in Los Angeles, CA, with subspecialties in breast cancer, hematologic oncology, and thoracic cancer. He completed his fellowship in hematology and medical oncology at the UCLA David Geffen School of Medicine/UCLA Medical Center, following an MD-PhD from the New York University School of Medicine. Dr. Hamburg is a clinical professor of medicine at both Cedars-Sinai and the UCLA David Geffen School of Medicine. He has extensive experience in procedures such as lumbar puncture and bone marrow biopsies and has been involved in research with several publications on topics including myelofibrosis and lymphoma. Dr. Hamburg is also involved in multiple clinical trials and has received various CMS Meaningful Use Stage certifications.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1984 - 1987
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1981 - 1984
  • New York University
    New York UniversityMD-PhD, Cell Biology, 1974 - 1981
  • New York University
    New York UniversityPh.D., Basic Medical Sciences, 1973 - 1981
  • New York University School of Medicine
    New York University School of MedicineClass of 1981, MD-PhD, Alpha Omega Alpha

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1984 - 2028
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2015, 2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2014-2015, 2017
  • CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2014-2015, 2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Interim analysis of safety and efficacy of ruxolitinib in patient with myelofibrosis and low platelet counts  
    Talpaz, M, Paquette, R, Afrin, L, Hamburg, S.I., et. al, J Hematology and Oncology, 1/1/2013
  • Heart transplantation using bivalirudin as anticoagulant  
    Simsir SA, Schwarz ER, Czer LS, Hamburg SI, Interact Cardiovasc Thorac Surg, 1/1/2010
  • Laparoscopic splenectomy for hairy cell leukemia in pregnancy  
    Adeniji BA, Fallas M, Incerpi M, Hamburg S, Datz R, Ogunyemi D, Case Report Med, 1/1/2010

Books/Book Chapters

  • Medical Screening for California Law Enforcement, 1993. 
    Chapter: Chapter V, Hematology 
    Hamburg, S.I.,Liebman, H.and Weitz, E.1993
  • Medical Screening for California Law Enforcement, 1993. 
    Chapter: Chapter VI, Oncology. 
    Hamburg, S.I.,Liebman, H.and Weitz, E.1993
  • Guide to Dental Problems for Physicians and Surgeons. 
    Chapter: Hemorrhagic Disorders. 
    Hamburg, S.I. and Rosove, M.Editors: S.R. Thaller and W.W. Montgomery.1988

Abstracts/Posters

  • Abstract LB-289: A phase I dose escalation study of TKM-080301, a RNAi therapeutic directed against PLK1, in patients with advanced solid tumors.
    Ramesh K. Ramanathan, Solomon I. Hamburg, Mitesh J. Borad, Mahesh Seetharam, Madappa N. Kundranda, Peter Lee, Paul Fredlund, Mark Gilbert, Cathy Mast, Sean C. Semple, ..., AACR, 1/15/2013
  • Preliminary Safety and Efficacy from a Phase II study of Ruxolitinib in Patients with Primary and Secondary Myelofibrosis with Platelet Counts of 50-100x109/L.
    Moshe Talpaz, Solomon I. Hamburg, Ktarzyna Jamieson, Howard R. Terebelo, Lawrence Afrin, Elliott F. Winton, Michael A. Scola, Roger M. Lyons, Jimmie Huling Harvey Jr.,..., ASCO, 1/1/2012
  • Results of a phase 1 dose-escalation study of once-weekly MLN9708, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphoma.
    Sarit E. Assouline, Julie Chang, Bruce D. Cheson, Robert Rifkin, Solomon Hamburg, Ruben Reyes, Ai-Min Hui, Jiang Yu, Neeraj Gupta, Alessandra Di Bacco, Yaping Shou, P..., ASCO, 1/1/2012

Lectures

  • Update in Therapy for P. Vera and Myelofibrosis 
    Cedars-Sinai Medical Center, Los Angeles, CA - 1/15/2016
  • Myelofibrosis 2014 
    Cedars-Sinai Medical Center, Los Angeles, CA - 1/26/2014
  • The Big Spleen: New diagnostic and management considerations. Myeloproliferative disorders. 
    Marina Del Rey, CA - 1/21/2012

Professional Memberships

Other Languages

  • Spanish

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Solomon Hamburg, Dr. Solomon Hamburg, MD, Dr. S Hamburg, Dr. Solomon I. Hamburg